Eli Silber

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Ross W. Paterson, Rachel Brown, Laura Benjamin et al. · Brain · 2020 · 1.2K citations · Full text

Medicine, Infectious Diseases, Neurology +17

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Sleep and fatigue in multiple sclerosis

Biba Stanton, Fiona Barnes, Eli Silber · Multiple Sclerosis Journal · 2006 · 226 citations

Medicine, Internal Medicine, Neurology +12

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

Neil Scolding, David Barnes, Sarah Cader et al. · Practical Neurology · 2015 · 220 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +9

Is Short-Term Palliative Care Cost-Effective in Multiple Sclerosis? A Randomized Phase II Trial

Irene J Higginson, Paul McCrone, Sam Hart et al. · Journal of Pain and Symptom Management · 2009 · 189 citations

Medicine, Internal Medicine, Neurology +11